Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf JE Jr; North American Parkinson's and Melanoma Survey Investigators.

Arch Neurol. 2010 Mar;67(3):347-52. doi: 10.1001/archneurol.2010.1.

PMID:
20212233
2.

Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.

Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR, Sikes RG, Vigeland K, Bachenberg EU, Menon PA, Billon SF, Goldberg G, Scarborough DA, Ramsdell WM, Muscarella VA, Lew RA.

J Am Acad Dermatol. 1996 Jun;34(6):971-8.

PMID:
8647990
3.

Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.

Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS.

J Am Acad Dermatol. 2007 Jul;57(1):60-6. Epub 2007 May 9.

PMID:
17490783
4.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
5.

Malignant melanoma and other types of cancer preceding Parkinson disease.

Olsen JH, Friis S, Frederiksen K.

Epidemiology. 2006 Sep;17(5):582-7.

PMID:
16837822
6.

Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.

Shore RN, Shore P, Monahan NM, Sundeen J.

J Drugs Dermatol. 2011 Mar;10(3):244-52.

PMID:
21369639
7.
8.

Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.

Haenssle HA, Korpas B, Hansen-Hagge C, Buhl T, Kaune KM, Johnsen S, Rosenberger A, Schön MP, Emmert S.

Arch Dermatol. 2010 Mar;146(3):257-64. doi: 10.1001/archdermatol.2009.370.

PMID:
20231495
9.
10.

High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.

Inzelberg R, Rabey JM, Melamed E, Djaldetti R, Reches A, Badarny S, Hassin-Baer S, Cohen O, Trau H, Aharon-Peretz J, Milo R, Schwartz M, Huberman M, Gilead L, Barchana M, Liphshiz I, Fitzer-Attas C, Giladi N.

J Neural Transm (Vienna). 2011 Aug;118(8):1199-207. doi: 10.1007/s00702-011-0580-2. Epub 2011 Feb 5.

PMID:
21298300
11.

Risk of second primary malignancies in patients with cutaneous melanoma.

Schmid-Wendtner MH, Baumert J, Wendtner CM, Plewig G, Volkenandt M.

Br J Dermatol. 2001 Dec;145(6):981-5.

PMID:
11899153
12.

Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications.

Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS.

Cancer. 1995 Jan 15;75(2 Suppl):707-14.

PMID:
7804999
13.
14.

Skin cancer and Parkinson's disease.

Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C.

Mov Disord. 2010 Jan 30;25(2):139-48. doi: 10.1002/mds.22855. Review.

PMID:
20063399
15.

Second malignancies in melanoma patients in Thuringia.

Wolff J, Wollina U.

J Eur Acad Dermatol Venereol. 2000 Nov;14(6):479-83.

PMID:
11444270
16.

Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.

Carli P, Balzi D, de Giorgi V, Massi D, Palli D, Chiarugi A, Nardini P, Giannotti B.

Eur J Dermatol. 2003 Sep-Oct;13(5):482-6.

PMID:
14693495
17.

Routine dermatologist-performed full-body skin examination and early melanoma detection.

Kantor J, Kantor DE.

Arch Dermatol. 2009 Aug;145(8):873-6. doi: 10.1001/archdermatol.2009.137.

PMID:
19687416
18.

The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.

Manganoni AM, Farisoglio C, Tucci G, Facchetti F, Calzavara Pinton PG.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1333-6.

PMID:
17958838
19.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
20.

Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.

Carli P, Nardini P, Crocetti E, De Giorgi V, Giannotti B.

Melanoma Res. 2004 Oct;14(5):403-7.

PMID:
15457097

Supplemental Content

Support Center